GlassScriptPhysician profile
Callie Clark
NPI 1487114484
$7,313.57
in general payments reported to CMS, 2019-2025
38 companies · $2,356 in 2025
The $2,356 reported for 2025 was more than what 95% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $522 · 2022: $921 · 2023: $1,769 · 2024: $1,747 · 2025: $2,356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,757 · Education: $114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,757.47 |
| Education | $113.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,499.46 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $748.62 | 2021-2025 | Xifaxan, Trulance |
| Qol Medical, LLC | $621.91 | 2021-2025 | Sucraid, Sucraid |
| Janssen Biotech, INC. | $474.00 | 2022-2025 | Stelara, Tremfya, Simponi |
| Ardelyx, INC. | $466.80 | 2022-2025 | Ibsrela |
| Takeda Pharmaceuticals U.S.A., INC. | $372.15 | 2021-2025 | Entyvio, Eohilia |
| Genzyme Corporation | $359.77 | 2022-2025 | |
| Celgene Corporation | $339.45 | 2022-2024 | Zeposia |
| Madrigal Pharmaceuticals | $249.28 | 2025 | Rezdiffra |
| Regeneron Healthcare Solutions, INC. | $198.86 | 2022-2025 | Dupixent |
| Evoke Pharma, INC. | $192.41 | 2022-2025 | Gimoti |
| Redhill Biopharma INC. | $188.81 | 2021-2022 | |
| Pfizer INC. | $174.34 | 2021-2024 | |
| Lilly USA, LLC | $145.87 | 2023-2025 | Omvoh |
| Aimmune Therapeutics, INC. | $141.79 | 2024-2025 | Vowst |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Callie Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.